CD163 and pancreatic adenocarcinoma: We collected 87 cases of PAAD pathological tissues from Harbin Medical University Cancer Hospital (Table 1) and conducted immunohistochemical staining for VDR, the M2 marker CD163, and the M1 marker CD86 (Fig. 2E).